Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts
about
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transitionUnderstanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentEpidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaEpidemiological and molecular mechanisms aspects linking obesity and cancer.Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis.Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study.Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trialDiabetes and pancreatic cancer.Mechanisms of obesity-induced gastrointestinal neoplasiaAssociation between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival.Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma PathophysiologyIGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects.Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancerHyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study.An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies.Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies.Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis.Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinib.Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients.Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected].Obesity and cancer
P2860
Q24632480-341F0B4F-6F16-434F-A81D-1AF4D850D303Q26798408-0A52A866-9575-456D-8F20-6081498D67C9Q26801418-E8F8980D-1C77-44C2-A8D7-CE22CB48A776Q30377470-994732AB-802C-458D-A0C1-0D67ECE7CAB6Q33616917-64F84EF4-E82F-49A9-AD81-1579CFD4759BQ33857217-1C9CEC1B-5E58-4CD4-8DFD-ED32281E14F1Q34021225-AA70C374-070D-41C8-9FBD-BDB310BBD23DQ34115984-C244C75C-F7C1-4AEC-81A1-697EFEB63A22Q34634263-8A438603-3DB3-4222-BBD4-0846C621021AQ35062195-97C64EC0-2B8F-43CB-BDE0-44BCDC0FBC3BQ35103474-4081B1AD-9F62-49D2-B4C0-0C83948C0B19Q35835118-B9779768-5FF4-4F52-9207-AC2D6419BF41Q35903573-8A5D70D9-2312-4311-BADC-9F7DC34CBFDAQ36516208-1CBD71B9-E73C-40CA-A536-873890B40C4AQ37010354-A24B0655-7AC6-4504-8E80-29166D96139CQ37021217-A8EC053E-0659-4E0E-A195-1F3E728F8533Q37203915-9A336BD9-2815-4924-8DCA-EDA74415844CQ37506586-E66C4705-256C-47F8-8F00-37757BAF1EECQ38017977-CE335DBA-5814-4984-BDD4-1BAFCC0A79CFQ38069964-CC98A483-C514-4ADB-B354-20B317EE3D3AQ39026672-A7546E0E-DEBF-4C16-B525-62503B15ECFBQ40133659-D003671F-0180-49FF-A7A0-21E45CD95004Q42745155-754FAB9C-8255-416D-8DC9-2C7020DC6C00Q46200583-8657A010-1BC2-4622-ACC4-45D6F55B8F55Q51217477-DD19A7BC-34E1-44A6-846B-7C38D46A6D97Q56988184-002B5778-D77D-4FEC-85F6-02DC7431D7C1
P2860
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Circulating insulin-like growt ...... er in four prospective cohorts
@ast
Circulating insulin-like growt ...... er in four prospective cohorts
@en
Circulating insulin-like growt ...... er in four prospective cohorts
@nl
type
label
Circulating insulin-like growt ...... er in four prospective cohorts
@ast
Circulating insulin-like growt ...... er in four prospective cohorts
@en
Circulating insulin-like growt ...... er in four prospective cohorts
@nl
prefLabel
Circulating insulin-like growt ...... er in four prospective cohorts
@ast
Circulating insulin-like growt ...... er in four prospective cohorts
@en
Circulating insulin-like growt ...... er in four prospective cohorts
@nl
P2093
P2860
P356
P1476
Circulating insulin-like growt ...... er in four prospective cohorts
@en
P2093
B B Cochrane
B M Wolpin
D S Michaud
E L Giovannucci
J E Manson
M J Stampfer
M N Pollak
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603826
P407
P577
2007-05-29T00:00:00Z
P5875
P6179
1030009962